0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Human Serum and Plasma Market Research Report 2026
Published Date: 2026-02-09
|
Report Code: QYRE-Auto-36P18258
Home | Market Reports | Health| Medical Devices & Equipment
Global Human Serum and Plasma Market Research Report 2024
BUY CHAPTERS

Global Human Serum and Plasma Market Research Report 2026

Code: QYRE-Auto-36P18258
Report
2026-02-09
Pages:116
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Human Serum and Plasma Market

The global Human Serum and Plasma market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Human Serum and Plasma competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Human plasma is an important component of blood. It is a liquid without cell components obtained by centrifugation after the whole blood leaves the blood vessels and is anticoagulated. Human serum refers to the light yellow transparent liquid separated from the plasma by removing fibrinogen after blood coagulation, or plasma without fibrinogen. It is an invisible component of blood and is different from plasma in composition.
The North American market for Human Serum and Plasma is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Human Serum and Plasma is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Human Serum and Plasma include Akron, Baxter, Cytiva, Merck Millipore, Monobind, SeraCare, TCS Biosciences Ltd, Thermo Fisher, Trina Bioreactives, Zen-Bio, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Human Serum and Plasma market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Human Serum and Plasma. The Human Serum and Plasma market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Human Serum and Plasma market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Human Serum and Plasma manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Human Serum and Plasma Market Report

Report Metric Details
Report Name Human Serum and Plasma Market
Segment by Type
  • Fresh Human Serum and Plasma
  • Frozen Human Serum and Plasma
by Application
  • In Vitro Diagnostics
  • Vaccines and Antibodies
  • Cell Culture
  • Clinical Research
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Akron, Baxter, Cytiva, Merck Millipore, Monobind, SeraCare, TCS Biosciences Ltd, Thermo Fisher, Trina Bioreactives, Zen-Bio
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Human Serum and Plasma manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Human Serum and Plasma sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Human Serum and Plasma Market report?

Ans: The main players in the Human Serum and Plasma Market are Akron, Baxter, Cytiva, Merck Millipore, Monobind, SeraCare, TCS Biosciences Ltd, Thermo Fisher, Trina Bioreactives, Zen-Bio

What are the Application segmentation covered in the Human Serum and Plasma Market report?

Ans: The Applications covered in the Human Serum and Plasma Market report are In Vitro Diagnostics, Vaccines and Antibodies, Cell Culture, Clinical Research, Others

What are the Type segmentation covered in the Human Serum and Plasma Market report?

Ans: The Types covered in the Human Serum and Plasma Market report are Fresh Human Serum and Plasma, Frozen Human Serum and Plasma

1 Human Serum and Plasma Market Overview
1.1 Product Definition
1.2 Human Serum and Plasma by Type
1.2.1 Global Human Serum and Plasma Market Value by Type: 2025 vs 2032
1.2.2 Fresh Human Serum and Plasma
1.2.3 Frozen Human Serum and Plasma
1.3 Human Serum and Plasma by Application
1.3.1 Global Human Serum and Plasma Market Value by Application: 2025 vs 2032
1.3.2 In Vitro Diagnostics
1.3.3 Vaccines and Antibodies
1.3.4 Cell Culture
1.3.5 Clinical Research
1.3.6 Others
1.4 Global Human Serum and Plasma Market Size Estimates and Forecasts
1.4.1 Global Human Serum and Plasma Revenue 2021–2032
1.4.2 Global Human Serum and Plasma Sales 2021–2032
1.4.3 Global Human Serum and Plasma Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Human Serum and Plasma Market Competition by Manufacturers
2.1 Global Human Serum and Plasma Sales Market Share by Manufacturers (2021–2026)
2.2 Global Human Serum and Plasma Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Human Serum and Plasma Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Human Serum and Plasma, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Human Serum and Plasma, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Human Serum and Plasma, Product Types and Applications
2.7 Global Key Manufacturers of Human Serum and Plasma, Date of Entry into the Industry
2.8 Global Human Serum and Plasma Market Competitive Situation and Trends
2.8.1 Global Human Serum and Plasma Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Human Serum and Plasma Players Market Share by Revenue
2.8.3 Global Human Serum and Plasma Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Human Serum and Plasma Market Scenario by Region
3.1 Global Human Serum and Plasma Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Human Serum and Plasma Sales by Region: 2021–2032
3.2.1 Global Human Serum and Plasma Sales by Region: 2021–2026
3.2.2 Global Human Serum and Plasma Sales by Region: 2027–2032
3.3 Global Human Serum and Plasma Revenue by Region: 2021–2032
3.3.1 Global Human Serum and Plasma Revenue by Region: 2021–2026
3.3.2 Global Human Serum and Plasma Revenue by Region: 2027–2032
3.4 North America Human Serum and Plasma Market Facts & Figures by Country
3.4.1 North America Human Serum and Plasma Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Human Serum and Plasma Sales by Country (2021–2032)
3.4.3 North America Human Serum and Plasma Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Human Serum and Plasma Market Facts & Figures by Country
3.5.1 Europe Human Serum and Plasma Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Human Serum and Plasma Sales by Country (2021–2032)
3.5.3 Europe Human Serum and Plasma Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Human Serum and Plasma Market Facts & Figures by Region
3.6.1 Asia Pacific Human Serum and Plasma Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Human Serum and Plasma Sales by Region (2021–2032)
3.6.3 Asia Pacific Human Serum and Plasma Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Human Serum and Plasma Market Facts & Figures by Country
3.7.1 Latin America Human Serum and Plasma Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Human Serum and Plasma Sales by Country (2021–2032)
3.7.3 Latin America Human Serum and Plasma Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Human Serum and Plasma Market Facts & Figures by Country
3.8.1 Middle East and Africa Human Serum and Plasma Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Human Serum and Plasma Sales by Country (2021–2032)
3.8.3 Middle East and Africa Human Serum and Plasma Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Human Serum and Plasma Sales by Type (2021–2032)
4.1.1 Global Human Serum and Plasma Sales by Type (2021–2026)
4.1.2 Global Human Serum and Plasma Sales by Type (2027–2032)
4.1.3 Global Human Serum and Plasma Sales Market Share by Type (2021–2032)
4.2 Global Human Serum and Plasma Revenue by Type (2021–2032)
4.2.1 Global Human Serum and Plasma Revenue by Type (2021–2026)
4.2.2 Global Human Serum and Plasma Revenue by Type (2027–2032)
4.2.3 Global Human Serum and Plasma Revenue Market Share by Type (2021–2032)
4.3 Global Human Serum and Plasma Price by Type (2021–2032)
5 Segment by Application
5.1 Global Human Serum and Plasma Sales by Application (2021–2032)
5.1.1 Global Human Serum and Plasma Sales by Application (2021–2026)
5.1.2 Global Human Serum and Plasma Sales by Application (2027–2032)
5.1.3 Global Human Serum and Plasma Sales Market Share by Application (2021–2032)
5.2 Global Human Serum and Plasma Revenue by Application (2021–2032)
5.2.1 Global Human Serum and Plasma Revenue by Application (2021–2026)
5.2.2 Global Human Serum and Plasma Revenue by Application (2027–2032)
5.2.3 Global Human Serum and Plasma Revenue Market Share by Application (2021–2032)
5.3 Global Human Serum and Plasma Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Akron
6.1.1 Akron Company Information
6.1.2 Akron Description and Business Overview
6.1.3 Akron Human Serum and Plasma Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Akron Human Serum and Plasma Product Portfolio
6.1.5 Akron Recent Developments/Updates
6.2 Baxter
6.2.1 Baxter Company Information
6.2.2 Baxter Description and Business Overview
6.2.3 Baxter Human Serum and Plasma Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Baxter Human Serum and Plasma Product Portfolio
6.2.5 Baxter Recent Developments/Updates
6.3 Cytiva
6.3.1 Cytiva Company Information
6.3.2 Cytiva Description and Business Overview
6.3.3 Cytiva Human Serum and Plasma Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Cytiva Human Serum and Plasma Product Portfolio
6.3.5 Cytiva Recent Developments/Updates
6.4 Merck Millipore
6.4.1 Merck Millipore Company Information
6.4.2 Merck Millipore Description and Business Overview
6.4.3 Merck Millipore Human Serum and Plasma Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Merck Millipore Human Serum and Plasma Product Portfolio
6.4.5 Merck Millipore Recent Developments/Updates
6.5 Monobind
6.5.1 Monobind Company Information
6.5.2 Monobind Description and Business Overview
6.5.3 Monobind Human Serum and Plasma Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Monobind Human Serum and Plasma Product Portfolio
6.5.5 Monobind Recent Developments/Updates
6.6 SeraCare
6.6.1 SeraCare Company Information
6.6.2 SeraCare Description and Business Overview
6.6.3 SeraCare Human Serum and Plasma Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 SeraCare Human Serum and Plasma Product Portfolio
6.6.5 SeraCare Recent Developments/Updates
6.7 TCS Biosciences Ltd
6.7.1 TCS Biosciences Ltd Company Information
6.7.2 TCS Biosciences Ltd Description and Business Overview
6.7.3 TCS Biosciences Ltd Human Serum and Plasma Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 TCS Biosciences Ltd Human Serum and Plasma Product Portfolio
6.7.5 TCS Biosciences Ltd Recent Developments/Updates
6.8 Thermo Fisher
6.8.1 Thermo Fisher Company Information
6.8.2 Thermo Fisher Description and Business Overview
6.8.3 Thermo Fisher Human Serum and Plasma Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Thermo Fisher Human Serum and Plasma Product Portfolio
6.8.5 Thermo Fisher Recent Developments/Updates
6.9 Trina Bioreactives
6.9.1 Trina Bioreactives Company Information
6.9.2 Trina Bioreactives Description and Business Overview
6.9.3 Trina Bioreactives Human Serum and Plasma Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Trina Bioreactives Human Serum and Plasma Product Portfolio
6.9.5 Trina Bioreactives Recent Developments/Updates
6.10 Zen-Bio
6.10.1 Zen-Bio Company Information
6.10.2 Zen-Bio Description and Business Overview
6.10.3 Zen-Bio Human Serum and Plasma Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Zen-Bio Human Serum and Plasma Product Portfolio
6.10.5 Zen-Bio Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Human Serum and Plasma Industry Chain Analysis
7.2 Human Serum and Plasma Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Human Serum and Plasma Production Mode & Process Analysis
7.4 Human Serum and Plasma Sales and Marketing
7.4.1 Human Serum and Plasma Sales Channels
7.4.2 Human Serum and Plasma Distributors
7.5 Human Serum and Plasma Customer Analysis
8 Human Serum and Plasma Market Dynamics
8.1 Human Serum and Plasma Industry Trends
8.2 Human Serum and Plasma Market Drivers
8.3 Human Serum and Plasma Market Challenges
8.4 Human Serum and Plasma Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Human Serum and Plasma Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Human Serum and Plasma Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Human Serum and Plasma Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Human Serum and Plasma Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Human Serum and Plasma Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Human Serum and Plasma Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Human Serum and Plasma Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Human Serum and Plasma Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Human Serum and Plasma, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Human Serum and Plasma, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Human Serum and Plasma, Product Types and Applications
 Table 12. Global Key Manufacturers of Human Serum and Plasma, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Human Serum and Plasma Companies by Tier (Tier 1, Tier 2, Tier 3), based on Human Serum and Plasma Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Human Serum and Plasma Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Human Serum and Plasma Sales by Region (K Units), 2021–2026
 Table 18. Global Human Serum and Plasma Sales Market Share by Region (2021–2026)
 Table 19. Global Human Serum and Plasma Sales by Region (K Units), 2027–2032
 Table 20. Global Human Serum and Plasma Sales Market Share by Region (2027–2032)
 Table 21. Global Human Serum and Plasma Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Human Serum and Plasma Revenue Market Share by Region (2021–2026)
 Table 23. Global Human Serum and Plasma Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Human Serum and Plasma Revenue Market Share by Region (2027–2032)
 Table 25. North America Human Serum and Plasma Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Human Serum and Plasma Sales by Country (K Units), 2021–2026
 Table 27. North America Human Serum and Plasma Sales by Country (K Units), 2027–2032
 Table 28. North America Human Serum and Plasma Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Human Serum and Plasma Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Human Serum and Plasma Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Human Serum and Plasma Sales by Country (K Units), 2021–2026
 Table 32. Europe Human Serum and Plasma Sales by Country (K Units), 2027–2032
 Table 33. Europe Human Serum and Plasma Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Human Serum and Plasma Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Human Serum and Plasma Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Human Serum and Plasma Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Human Serum and Plasma Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Human Serum and Plasma Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Human Serum and Plasma Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Human Serum and Plasma Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Human Serum and Plasma Sales by Country (K Units), 2021–2026
 Table 42. Latin America Human Serum and Plasma Sales by Country (K Units), 2027–2032
 Table 43. Latin America Human Serum and Plasma Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Human Serum and Plasma Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Human Serum and Plasma Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Human Serum and Plasma Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Human Serum and Plasma Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Human Serum and Plasma Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Human Serum and Plasma Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Human Serum and Plasma Sales (K Units) by Type (2021–2026)
 Table 51. Global Human Serum and Plasma Sales (K Units) by Type (2027–2032)
 Table 52. Global Human Serum and Plasma Sales Market Share by Type (2021–2026)
 Table 53. Global Human Serum and Plasma Sales Market Share by Type (2027–2032)
 Table 54. Global Human Serum and Plasma Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Human Serum and Plasma Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Human Serum and Plasma Revenue Market Share by Type (2021–2026)
 Table 57. Global Human Serum and Plasma Revenue Market Share by Type (2027–2032)
 Table 58. Global Human Serum and Plasma Price (US$/Unit) by Type (2021–2026)
 Table 59. Global Human Serum and Plasma Price (US$/Unit) by Type (2027–2032)
 Table 60. Global Human Serum and Plasma Sales (K Units) by Application (2021–2026)
 Table 61. Global Human Serum and Plasma Sales (K Units) by Application (2027–2032)
 Table 62. Global Human Serum and Plasma Sales Market Share by Application (2021–2026)
 Table 63. Global Human Serum and Plasma Sales Market Share by Application (2027–2032)
 Table 64. Global Human Serum and Plasma Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Human Serum and Plasma Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Human Serum and Plasma Revenue Market Share by Application (2021–2026)
 Table 67. Global Human Serum and Plasma Revenue Market Share by Application (2027–2032)
 Table 68. Global Human Serum and Plasma Price (US$/Unit) by Application (2021–2026)
 Table 69. Global Human Serum and Plasma Price (US$/Unit) by Application (2027–2032)
 Table 70. Akron Company Information
 Table 71. Akron Description and Business Overview
 Table 72. Akron Human Serum and Plasma Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. Akron Human Serum and Plasma Product
 Table 74. Akron Recent Developments/Updates
 Table 75. Baxter Company Information
 Table 76. Baxter Description and Business Overview
 Table 77. Baxter Human Serum and Plasma Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. Baxter Human Serum and Plasma Product
 Table 79. Baxter Recent Developments/Updates
 Table 80. Cytiva Company Information
 Table 81. Cytiva Description and Business Overview
 Table 82. Cytiva Human Serum and Plasma Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. Cytiva Human Serum and Plasma Product
 Table 84. Cytiva Recent Developments/Updates
 Table 85. Merck Millipore Company Information
 Table 86. Merck Millipore Description and Business Overview
 Table 87. Merck Millipore Human Serum and Plasma Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. Merck Millipore Human Serum and Plasma Product
 Table 89. Merck Millipore Recent Developments/Updates
 Table 90. Monobind Company Information
 Table 91. Monobind Description and Business Overview
 Table 92. Monobind Human Serum and Plasma Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. Monobind Human Serum and Plasma Product
 Table 94. Monobind Recent Developments/Updates
 Table 95. SeraCare Company Information
 Table 96. SeraCare Description and Business Overview
 Table 97. SeraCare Human Serum and Plasma Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 98. SeraCare Human Serum and Plasma Product
 Table 99. SeraCare Recent Developments/Updates
 Table 100. TCS Biosciences Ltd Company Information
 Table 101. TCS Biosciences Ltd Description and Business Overview
 Table 102. TCS Biosciences Ltd Human Serum and Plasma Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 103. TCS Biosciences Ltd Human Serum and Plasma Product
 Table 104. TCS Biosciences Ltd Recent Developments/Updates
 Table 105. Thermo Fisher Company Information
 Table 106. Thermo Fisher Description and Business Overview
 Table 107. Thermo Fisher Human Serum and Plasma Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 108. Thermo Fisher Human Serum and Plasma Product
 Table 109. Thermo Fisher Recent Developments/Updates
 Table 110. Trina Bioreactives Company Information
 Table 111. Trina Bioreactives Description and Business Overview
 Table 112. Trina Bioreactives Human Serum and Plasma Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 113. Trina Bioreactives Human Serum and Plasma Product
 Table 114. Trina Bioreactives Recent Developments/Updates
 Table 115. Zen-Bio Company Information
 Table 116. Zen-Bio Description and Business Overview
 Table 117. Zen-Bio Human Serum and Plasma Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 118. Zen-Bio Human Serum and Plasma Product
 Table 119. Zen-Bio Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Human Serum and Plasma Distributors List
 Table 123. Human Serum and Plasma Customers List
 Table 124. Human Serum and Plasma Market Trends
 Table 125. Human Serum and Plasma Market Drivers
 Table 126. Human Serum and Plasma Market Challenges
 Table 127. Human Serum and Plasma Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Human Serum and Plasma
 Figure 2. Global Human Serum and Plasma Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Human Serum and Plasma Market Share by Type: 2025 & 2032
 Figure 4. Fresh Human Serum and Plasma Product Picture
 Figure 5. Frozen Human Serum and Plasma Product Picture
 Figure 6. Global Human Serum and Plasma Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Human Serum and Plasma Market Share by Application: 2025 & 2032
 Figure 8. In Vitro Diagnostics
 Figure 9. Vaccines and Antibodies
 Figure 10. Cell Culture
 Figure 11. Clinical Research
 Figure 12. Others
 Figure 13. Global Human Serum and Plasma Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 14. Global Human Serum and Plasma Market Size (US$ Million), 2021–2032
 Figure 15. Global Human Serum and Plasma Sales (K Units), 2021–2032
 Figure 16. Global Human Serum and Plasma Average Price (US$/Unit), 2021–2032
 Figure 17. Human Serum and Plasma Report Years Considered
 Figure 18. Human Serum and Plasma Sales Share by Manufacturers in 2025
 Figure 19. Global Human Serum and Plasma Revenue Share by Manufacturers in 2025
 Figure 20. Top 5 and Top 10 Global Human Serum and Plasma Players: Market Share by Revenue in Human Serum and Plasma in 2025
 Figure 21. Human Serum and Plasma Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 22. Global Human Serum and Plasma Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 23. North America Human Serum and Plasma Sales Market Share by Country (2021–2032)
 Figure 24. North America Human Serum and Plasma Revenue Market Share by Country (2021–2032)
 Figure 25. United States Human Serum and Plasma Revenue Growth Rate (US$ Million), 2021–2032
 Figure 26. Canada Human Serum and Plasma Revenue Growth Rate (US$ Million), 2021–2032
 Figure 27. Europe Human Serum and Plasma Sales Market Share by Country (2021–2032)
 Figure 28. Europe Human Serum and Plasma Revenue Market Share by Country (2021–2032)
 Figure 29. Germany Human Serum and Plasma Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. France Human Serum and Plasma Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. U.K. Human Serum and Plasma Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Italy Human Serum and Plasma Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Russia Human Serum and Plasma Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. Asia Pacific Human Serum and Plasma Sales Market Share by Region (2021–2032)
 Figure 35. Asia Pacific Human Serum and Plasma Revenue Market Share by Region (2021–2032)
 Figure 36. China Human Serum and Plasma Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. Japan Human Serum and Plasma Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. South Korea Human Serum and Plasma Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. India Human Serum and Plasma Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Australia Human Serum and Plasma Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. China Taiwan Human Serum and Plasma Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Southeast Asia Human Serum and Plasma Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Latin America Human Serum and Plasma Sales Market Share by Country (2021–2032)
 Figure 44. Latin America Human Serum and Plasma Revenue Market Share by Country (2021–2032)
 Figure 45. Mexico Human Serum and Plasma Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Brazil Human Serum and Plasma Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Argentina Human Serum and Plasma Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Colombia Human Serum and Plasma Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Middle East and Africa Human Serum and Plasma Sales Market Share by Country (2021–2032)
 Figure 50. Middle East and Africa Human Serum and Plasma Revenue Market Share by Country (2021–2032)
 Figure 51. Turkey Human Serum and Plasma Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Saudi Arabia Human Serum and Plasma Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. UAE Human Serum and Plasma Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. Global Sales Market Share of Human Serum and Plasma by Type (2021–2032)
 Figure 55. Global Revenue Market Share of Human Serum and Plasma by Type (2021–2032)
 Figure 56. Global Human Serum and Plasma Price (US$/Unit) by Type (2021–2032)
 Figure 57. Global Sales Market Share of Human Serum and Plasma by Application (2021–2032)
 Figure 58. Global Revenue Market Share of Human Serum and Plasma by Application (2021–2032)
 Figure 59. Global Human Serum and Plasma Price (US$/Unit) by Application (2021–2032)
 Figure 60. Human Serum and Plasma Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India

SIMILAR REPORTS